Purified anti-mouse Keratin 6A Antibody (Previousl
- 产品名称：
- Purified anti-mouse Keratin 6A Antibody (Previousl
- 产品类别：
- 抗体
- 产品编号：
- 905702
- 产品应用：
- 905702
- Verified Reactivity
- Mouse
- Antibody Type
- Polyclonal
- Host Species
- Rabbit
- Immunogen
- This monospecific polyclonal antibody was raised against a peptide sequence derived from the C-terminus of the mouse keratin 6 protein.
- Formulation
- Phosphate-buffered solution + 0.03% Thimerosal.
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 1.0 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
- Application
-
IHC-P - Quality tested
WB - Verified
- Recommended Usage
Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining.
The optimal working dilution should be determined for each specific assay condition.
? WB: 1:1,000*
? IF: 1:500
? IHC: 1:500
- Application Notes
This antibody is effective in immunoblotting (WB), immunofluorescence (IF) and immunohistochemistry (IHC). This antibody has been successfully used in both frozen and paraffin embedded tissues.
*Predicted MW = 59.9 kD
This product may contain other non-IgG subtypes.
- Application References
(PubMed link indicates BioLegend citation) -
- Welm AL, et al. 2005. Proc Natl Acad Sci USA. 102:4324.
- Hu Y, et al. 2001. Nature. 410:710.
- Yuspa SH, et al.. 1989. J Cell Biol. 109:1207.
- Roop DR, et al. 1984. J Biol Chem. 259:8037.
- Easter SL, et al. 2014. PLoS One. 9:113247. (IF, WB) PubMed
- DiTommaso T, et al. 2014. PLoS Genet. 10:1004706. (IHC) PubMed
- Li Z, et al. 2007. Cancer Cell. 12:542. (IHC)
- Liang Y, 2011 Patholog Res Int. 2011:936794. (IHC) PubMed
- Frew IJ, et al. 2008. Mol Cell Biol.28:4536. (IHC) PubMed
- Smith BA, et al. 2012. Genes Cancer.3:550. (IHC) PubMed
- Johnson JP, et al. 2014 Cancer Geomics Proteomics. 11:115. (IHC) PubMed
- Sengupta A, et al. 2010. PLoS One. 5:12249. (IHC) PubMed
- Mikaelian I, et al. 2006. Vet Pathol. 43:36. (IHC)
- Li W, et al. 2007. J Biol Chem. 282:1161. (IHC, WB) PubMed
- Osmanagic-Myers S, et al.2006. J Cell Biol. 174:557. (WB) PubMed
- Kittrell FS, et al. 2011. Breast Cancer Res.13:41. (IF) PubMed
- Quante T, et al. 2014. Front Oncol. 26:168. (IF) PubMed
- Bayo P, Sanchis A, Bravo A, Cascallana JL, Buder K, Tuckermann J, Schütz G, and Pérez P. Glucocorticoid Receptor Is Required for Skin Barrier Competence. Endocrinology, 149: 1377-1388, Mar 2008. (IHC) PubMed
- Product Citations
-
- Sengupta A, et al. 2010. PLoS One. 5:e12249. PubMed
- Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
- Kashgari G, et al. 2020. Developmental Cell. 52(6):764-778. PubMed
- Avigad Laron E, et al. 2018. Cell Rep. 24:909. PubMed
- Whiteley J, et al. 2018. Stem Cells Transl Med. 7:591. PubMed
- Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
- Badolati N, et al. 2018. Nutrients. 10:. PubMed
- Sweat YY, et al. 2020. J Dent Res. 99:1397. PubMed
- Bornes L, et al. 2021. Life Sci Alliance. 4:00. PubMed
- Chen S, et al. 2015. Sci Rep. 5: 18104. PubMed
- Laurien L, et al. 2020. Nat Commun. 11:1747. PubMed
- Sarper SE, et al. 2019. Dis Model Mech. 12. PubMed
- Schünke H, et al. 2021. Nat Commun. 12:5912. PubMed
- Smith B, et al. 2012. Genes Cancer. 3:550-563. PubMed
- Jiao H, et al. 2020. Nature. 580:391. PubMed
- Xu M, et al. 2019. Am J Transl Res. 11:257. PubMed
- Xu KK, et al. 2020. Invest Ophthalmol Vis Sci. 61:30:00. PubMed
- Altmeier S, et al. 2016. PLoS Pathog. 12: 1005882. PubMed
- Carceller E, et al. 2016. Sci Rep. 6:38825. PubMed
- Rogerson C, et al. 2018. Biochim Biophys Acta. 37:2022. PubMed
- Weber MS, et al. 2021. Elife. 10: . PubMed
- Seldin L, et al. 2020. Developmental Cell. 55(5):558-573.e6. PubMed
- Turpin J, et al. 2016. Oncogene. 10.1038/onc.2016.129. PubMed
- Osmanagic-Myers S, et al. 2006. J Cell Biol. 174:557-568. PubMed
- Bayo P, et al. 2008. Endocrinology. 149:1377-1388. PubMed
- Dedeić Z, et al. 2018. Cell Death Differ. 25:1289. PubMed
- Liang Y 2011. Patholog Res Int. 2011:936794. PubMed
- Kittrell F, et al. 2011. Breast Cancer Res. 13:R41. PubMed
- Easter S, et al. 2014. PLoS One. 9:e113247. PubMed
- Fang X, et al. 2019. Am J Pathol. 189:1212. PubMed
- Buonanno M, et al. 2016. PLoS One. 11: 0138418. PubMed
- Li W, et al. 2007. J Biol Chem. 282:1161-1169. PubMed
- Jee JP, et al. 2019. Int J Nanomedicine. 14:5449. PubMed
- Reehorst CM, et al. 2021. Development. 148:. PubMed
- Quante T, et al. 2014. Front Oncol. 4:168. PubMed
- Frew I, et al. 2008. Mol Cell Biol. 28:4536-4548. PubMed
- Crompton R, et al. 2016. Lab Invest. 10.1038/labinvest.2015.160. PubMed
- Shatirishvili M, et al. 2016. Cell Death Dis. 7:e2461. PubMed
- Kousa YA, et al. 2017. Dev Dyn. 246:670. PubMed
- Jozic I, et al. 2021. Commun Biol. 4:757. PubMed
- DiTommaso T, et al. 2014. PLoS Genet. 10:e1004706. PubMed
- Johnson J, et al. 2014. Cancer Genomics Proteomics. 11:115-126. PubMed
- Lin J, et al. 2016. Nature. 540:124-128. PubMed
- Shwartz Y, et al. 2020. Cell. 182:578. PubMed
- Kim CS, et al. 2020. Cell Metabolism. 32(4):629-642.e8. PubMed
- Norum JH, et al. 2019. Int J Cancer. web only. PubMed
- Coelho P, et al. 2015. Open Bio. 5: 150209. PubMed
- Anderton H, et al. 2018. Cell Death Differ. 26:877. PubMed
- Cottle DL, et al. 2020. Cell Rep Med. 1:100129. PubMed
- Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
- Anderton H, et al. 2017. J Invest Dermatol. 137:2371. PubMed
- Seong J, et al. 2018. Development. 145:14. PubMed
- RRID
- AB_2734680 (BioLegend Cat. No. 905702) AB_2565052 (BioLegend Cat. No. 905701)
